VY
Vynleads, Inc.
VYND · OTC
$0.41 +0.00% (+$0.00)
Market Cap $7.51M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.34
17.0% downside
Current Price
$0.41
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VYND is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 124.00%
ROA 1,018.92%
Debt
0 /100
High Int. coverage -74.52x
Current ratio 0.06x
Debt/Assets N/A
Stability
44 /100
Moderate Profitable years 0
Beta 5.00x
EPS volatility 14.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VYND
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Alex J. Mannine
Employees
1
Headquarters
Rock Hill